These findings are of clinical importance since PSMA-positivity of tumor manifestations is predictive for the efficacy of PSMA-directed radioligand-therapy and is usually defined as tumoral PSMA-expression above the hepatic background activity using [68Ga]Ga-PSMA-11 [2, 16]. This evidence concerns the gene FOLH1 and neoplasm.